Gastric cancer: The French survey

Acta Gastro-Enterologica Belgica

Volumn 65, Issue 3, 2002, Pages 161-165

  Meyer, Ch ^a   Lozac'h, P ^a   Rohr, S ^a   Topar, P ^a   Youssef, Ch ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANEMIA; CANCER PAIN; CANCER STAGING; CANCER SURVIVAL; CONFERENCE PAPER; FEMALE; FRANCE; GASTRECTOMY; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; STOMACH CANCER; SURGICAL TECHNIQUE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

AGED; FEMALE; FRANCE; HUMANS; MALE; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 0036659090     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. Parkin D.M., Pisani P., Ferlay J. Estimate of the worldwide incidence of eighteen major cancers in, 1985. Int. J. Cancer, 1993, 54: 1-13.
2. Berrino F., Sant M., Verdecchia A., Capocaccia R., Hakulinen T., Esteve J. Survival of cancer patients in Europe. The Eurocare study. IARC Scientific Publication n°132, Lyon, 1995.
3. Faivre J., Grosclaude P., Launoy G., Arveux P., Raverdy N., Menegoz F. Les cancers digestifs en France. Distribution géographique et estimation de l'incidence nationale. Gastroenterol. Clin. Biol., 1997, 21: 174-80.
4. Faivre J., Justrabo E., Hillon P., Milan C., Klepping C. Gastric carcinoma in Côte-d'Or (France). A population based study. Gastroenterology, 1985, 88: 1874-9.
5. Berthet B., Le Treut Y., Lebreuil G., Botti G., Brico R. Valeur pronostique du curage ganglionnaire élargi (R2) dans les résections curatives des cancers de l'estomac. A propos d'une série de 100 patients. Chirurgie, 1996, 121: 108-12.
6. Mendes De Almeida J.C., Bettencourt A., Santos Costa C., Mendes De Almeida J.M. Curative surgery for gastric cancer, study of 166 consecutive patients. World J. Surg., 1994, 18: 889-95.
7. Pacelli F., Doglietto G.B., Bellantone R., Alfieri S., Sgadari A., Crucitti F. Extensive versus limited lymph node dissection for gastric cancer: a comparative study of 320 patients. Br. J. Surg., 1993, 80: 1153-6.
8. Söreide J.A., Van Heerden J.A., Burgart L.J., Donohue J.H., Sarr M.G., Illstrup D.M. Surgical aspects of patients with adenocarcinoma of the stomach operated on for cure. Arch. Surg., 1996, 131: 481-7.
9. Siewert J.R., Bottcher K., Roder J.D., Busch R., Hermanek P., Meyer H.J. Pronostic relevance of systematic lymph node dissection in gastric carcinoma. Br. J. Surg., 1993, 80: 1015-8.
10. Smith J.W.W., Shiu M.H., Kelsey L., Brennan M.F. Morbidity of radical lymphadenectomy in the curative resection of gastric carcinoma. Arch. Surg., 1991, 126: 1469-73.
11. Bonenkamp J.J., Songun I., Hermans J., Sasako M., Welvaart K., Plukker J.T.M. Randomise comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet, 1995, 345: 745-8.
12. Cuschieri A., Fayers P., Fielding J., Craven J., Bancewicz J., Joypaul V., Cook P. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Lancet, 1996, 347: 995-9.
13. Maruyama K., Sasako M., Kinoshita T., Sano T., Katai H., Okajima K. Pancreas preserving total gastrectomy for proximal gastric cancer. World J. Surg., 1995, 19: 532-6.
14. Noguchi Y., Imada T., Matsumoto A., Coit D.G., Bennan M.F. Radical surgery for gastric cancer, a review of the japanese experience. Cancer, 1989, 64: 2053-62.
15. Sasako M., Mc Culloch P., Kinoshita T., Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br. J. Surg., 1995, 82: 346-51.
16. Shiu M.H., Perroti M., Brennan M.F. Adenocareinoma of the stomach: a multivariate analysis of clinical, pathologic and treatment factors. Hepatogastroenterol., 1989, 36: 7-12.
17. Elias D. Technique chirurgicale des curages ganglionnaires étendus (de type R2 et R3) pour adénocarcinomes gastriques. Ann. Chir. 1995, 49: 13-20.
18. Jaehne J., Meyer H.J., Maschek H. Lymphadenectomy in gastric carcinoma. A prospective and prognostic study. Arch. Surg., 1992, 127: 290-4.
19. Kim J.P., Kim Y.W., Yang H.K., Noh D.Y. Significant prognostic factors by multivariate analysis of 3 926 gastric cancer patients. World J. Surg., 1994, 18: 872-8.
20. Lee W.J., Lee W.C., Houng S.J., Shun C.T., Houng R.L., Lee P.H. Survival after resection of gastric cancer and pronostic relevance of systematic lymph node dissection: twenty years experience in taiwan. World J. Surg., 1995, 19: 707-13.
21. Roder J.D., Bonenkamp J.J., Craven J., Van De Velde C.J.H., Sasako M., Böttcher K., Stein H.J. Lymphadenectomy for gastric cancer in clinical trials: update. World J. Surg., 1995, 19: 546-53.
22. Wanebo H.J., Kennedy B.J., Chimel J., Steele G., Winchester D., Osteen R. Cancer of the stomach: a patient care study by the American College Of Surgeons. Ann. Surg., 1993, 18: 583.
23. Bonenkamp J.J., Hermans J., Sasako M., Van De Velde C.J.H. Extended lymph-node dissection for gastric cancer. N. Eng J. Med., 1999, 370: 908-914.
24. Akoh J.A., Mc Intyre I.M.C. Improving survival in gastric cancer: review of 5 years survival rates in english language publications from, 1970. Br. J. Surg., 1992, 79: 293-9.
25. Okusa T., Nakane Y., Body T. Quantitative analysis of nodal involvement with respect to survival rate after curative gastrectomy for carcinoma. Surg. Gynecol. Obstet., 1990, 170: 488-93.
26. Maruyama K., Okabayashi K., Kinoshita T. Progress in the gastric cancer surgery in Japan and its limits of radicality. World. J. Surg., 1987, 11: 418-25.
27. Bittner R., Butters M., Ulrich M., Uppenbrink S., Beger H.G. Total Gastrectomy. Updated operative mortality and long term survival with particular reference to patients older than 70 years of age. Ann. Surg., 1996, 224: 37-42.
28. Bunt A.M.G., Hogendoorn P.C., Van De Velde C.J.H., Bruijn J.A.Z., Hermans J. Lymph node staging in gastric cancer. J. Clin. Oncol., 1995, 13: 2309-16.
29. Farthmann E.H., Kirchner R., Salm R., Strasser C., Frommhold H., Nilles A. Apports et limites de la radiothérapie peropératoire associée à l'exérèse-curage dans le traitement des cancers gastriques. Chirurgie, 1994, 119: 565-8.
30. Feinstein A.R., Sosin D.M., Wells C.K. The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N. Engl. J. Med., 1985, 312: 1604-6.
31. Lepage M., Cauvin J.M., Ledreau G., Nousbaum J.B., Enard L. Sourlaouen A. Prise en charge thérapeutique et survie de l'adénocarcinome gastrique dans le département du Finistère entre 1984 et 1989. Gastroenterol. Clin. Biol., 1995, 19: 804-10.